AKBA - CIK 0001517022
Akebia Therapeutics, Inc. has filed 868 documents with the SEC between 2011 and 2026. The most frequent type is insider trade (318 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Insider trade | 4 | 2023-05-16 | 2023-05-12 |
| Insider sale notice | 144 | 2023-05-16 | - |
| Insider sale notice | 144 | 2023-05-16 | - |
| Major company event | 8-K | 2023-05-09 | 2023-05-09 |
| Quarterly report | 10-Q | 2023-05-08 | 2023-03-31 |
| Major company event | 8-K | 2023-05-08 | 2023-05-08 |
| Major company event | 8-K | 2023-05-08 | 2023-05-04 |
| Annual report to shareholders | ARS | 2023-04-28 | 2022-12-31 |
| Proxy statement | DEF 14A | 2023-04-28 | - |
| Major company event | 8-K | 2023-04-28 | 2023-04-27 |
| Major company event | 8-K | 2023-04-25 | 2023-04-25 |
| Proxy materials | DEFA14A | 2023-04-21 | - |
| Proxy materials | DEFA14A | 2023-04-14 | - |
| Proxy materials | DEFA14A | 2023-04-14 | - |
| Proxy materials | DEFA14A | 2023-04-11 | - |
| Major company event | 8-K | 2023-04-11 | 2023-04-11 |
| Proxy materials | DEFA14A | 2023-03-31 | - |
| Proxy materials | DEFA14A | 2023-03-27 | - |
| Proxy materials | DEFA14A | 2023-03-27 | - |
| Proxy materials | DEFA14A | 2023-03-27 | - |
| Proxy materials | DEFA14A | 2023-03-24 | - |
| DEFR14A | - | 2023-03-17 | - |
| Annual report | 10-K | 2023-03-10 | 2022-12-31 |
| Major company event | 8-K | 2023-03-09 | 2023-03-09 |
| Insider trade | 4 | 2023-03-03 | 2023-03-01 |
| Insider trade | 4 | 2023-03-03 | 2023-03-01 |
| Insider trade | 4 | 2023-03-03 | 2023-03-01 |
| Insider trade | 4 | 2023-03-03 | 2023-03-01 |
| Insider trade | 4 | 2023-03-03 | 2023-03-01 |
| Major company event | 8-K | 2023-03-02 | 2023-02-28 |
| Insider trade | 4 | 2023-03-01 | 2023-02-27 |
| Insider trade | 4 | 2023-03-01 | 2023-02-27 |
| Insider trade | 4 | 2023-03-01 | 2023-02-27 |
| Insider trade | 4 | 2023-03-01 | 2023-02-27 |
| Insider trade | 4 | 2023-03-01 | 2023-02-27 |
| Proxy statement | DEF 14A | 2023-03-01 | 2023-04-11 |
| Major company event | 8-K | 2023-02-21 | 2023-02-21 |
| PRE 14A | - | 2023-02-17 | 2023-04-11 |
| Passive ownership stake (update) | SC 13G/A | 2023-02-10 | - |
| Passive ownership stake (update) | SC 13G/A | 2023-02-09 | - |
| Insider trade | 4 | 2023-02-02 | 2023-01-31 |
| Insider trade | 4 | 2023-02-02 | 2023-01-31 |
| Insider trade | 4 | 2023-02-02 | 2023-01-31 |
| Employee stock plan | S-8 | 2023-01-30 | - |
| Passive ownership stake (update) | SC 13G/A | 2023-01-20 | - |
| Major company event | 8-K | 2023-01-09 | 2023-01-09 |
| Major company event | 8-K | 2022-12-28 | 2022-12-22 |
| Passive ownership stake | SC 13G | 2022-12-19 | - |
| Major company event | 8-K | 2022-12-15 | 2022-12-14 |
| CT ORDER | - | 2022-12-13 | - |